Skip to main content Accessibility help

Role of Matching in Case-Control Studies of Antimicrobial Resistance

  • Elizabeth Cerceo (a1), Ebbing Lautenbach (a1) (a2) (a3) (a4), Darren R. Linkin (a2) (a4), Warren B. Bilker (a2) (a3) (a4) and Ingi Lee (a1) (a3) (a4)...


Of 57 case-control studies of antimicrobial resistance, matching was used in 23 (40%). Matched variables differed substantially across studies. Of these 23 matched case-control studies, 12 (52%) justified the use of matching, and 9 (39%) noted the strengths or limitations of this approach. Analysis that accounted for matching was performed in only 52% of the case-control studies.


Corresponding author

Division of Infectious Diseases, Hospital of the University of Pennsylvania, 3400 Spruce Street, 3rd Floor, Silverstein Building, Suite E, Philadelphia, PA 19104)


Hide All
1.Straelens, M. The epidemiology of antimicrobial resistance in hospital acquired infections: problems and possible solutions. BMJ 1998;317:652654.
2.Gold, H, Moellering, R. Antimicrobial-drug resistance. N Engl J Med 1996;335:14451453.
3.Hennekens, CH, Buring, JE. Epidemiology in Medicine. Philadelphia, PA: Lippincott, Williams & Wilkins; 1987.
4.Woodward, M. Epidemiology: Study Design and Data Analysis. Boca Raton, FL: Chapman and Hall/CRC Press; 2005.
5.Malvy, D, Treilhaud, M, Bouee, S, et al. A retrospective, case-control study of acyclovir resistance in herpes simplex virus. Clin Infect Dis 2005;41:320326.
6.Lee, NE, Taylor, MM, Bancroft, E, et al. Risk factors for community-associated methicillin-resistant Staphylococcus aureus skin infections among HIV-positive men who have sex with men (published correction appears in Clin Infect Dis 2005;41:135). Clin Infect Dis 2005;40:15291534.
7.Falagas, M, Mourtzoukou, E, Ntziora, F, Peppas, G, Rafailidis, P. Matching criteria in case-control studies on postoperative infections. J Hosp Infect 2008;69:101113.
8.Soriano, A, Martinez, JA, Mensa, J, et al. Pathogenic significance of methicillin resistance for patients with Staphylococcus aureus bacteremia. Clin Infect Dis 2000;30:368373.
9.Vasquez, J, Walker, E, Franzus, B, Overbay, B, Reagan, D, Sarubbi, F. The epidemiology of mupirocin resistance among methicillin-resistant Staphylococcus aureus at a veterans' affairs hospital. Infect Control Hosp Epidemiol 2000;21:459464.
10.Byers, K, Anglim, A, Anneski, C, et al. A hospital epidemic of vancomycin-resistant Enterococcus: risk factors and control. Infect Control Hosp Epidemiol 2001;22:140147.
11.Ho, P, Tse, W, Tsang, K, et al. Risk factors for acquisition of levofloxacin-resistant Streptococcus pneumoniae: a case-control study. Clin Infect Dis 2001;32:701707.
12.Lautenbach, E, Patel, J, Bilker, W, Edelstein, P, Fishman, N. Extended-spectrum β-lactamase-producing Escherichia coli and Klebsiella pneumoniae: risk factors for infection and impact of resistance on outcomes. Clin Infect Dis 2001;32:11621171.
13.Moroney, J, Fiore, A, Harrison, L, et al. Clinical outcomes of bacteremic pneumococcal pneumonia in the era of antibiotic resistance. Clin Infect Dis 2001;33:797805.
14.Tacconelli, E, Tumbarello, M, de Gaetano Donati, K, et al. Glycopeptide resistance among coagulase-negative staphylococci that cause bacteremia: epidemiological and clinical findings from a case-control study. Clin Infect Dis 2001;33:16281635.
15.Harris, AD, Karchmer, TB, Carmeli, Y, Samore, MH. Methodological principles of case-control studies that analyzed risk factors for antibiotic resistance: a systematic review. Clin Infect Dis 2001;32:10551061.
16.Carmeli, Y, Eliopoulos, G, Samore, M. Antecedent treatment with different antibiotic agents as a risk factor for vancomycin-resistant Enterococcus. Emerg Infect Dis 2002;8:802807.
17.Cetinkaya, Y, Falk, P, Mayhall, C. Effect of gastrointestinal bleeding and oral medications on acquisition of vancomycin-resistant Enterococcus fae-cium in hospitalized patients. Clin Infect Dis 2002;35:935942.
18.Lodise, T, McKinnon, P, Tam, V, Rybak, M. Clinical outcomes for patients with bacteremia caused by vancomycin-resistant Enterococcus in a level 1 trauma center. Clin Infect Dis 2002;34:922929.
19.Lonks, J, Garau, J, Gomez, L, et al. Failure of macrolide antibiotic treatment in patients with bacteremia due to erythromycin-resistant Streptococcus pneumoniae. Clin Infect Dis 2002;35:556564.
20.Hirakata, Y, Yamaguchi, T, Nakano, M, et al. Clinical and bacteriological characteristics of IMP-type metallo-β-lactamase-producing Pseudomonas aeruginosa. Clin Infect Dis 2003;37:2632.
21.Jernigan, J, Pullen, A, Flowers, L, Bell, M, Jarvis, W. Prevalence of and risk factors for colonization with methicillin-resistant Staphylococcus aureus at the time of hospital admission. Infect Control Hosp Epidemiol 2003; 24:409414.
22.Kang, C, Kim, S, Kim, D, et al. Risk factors for and clinical outcomes of bloodstream infections caused by extended-spectrum beta-lactamase-producing Klebsiella pneumoniae. Infect Control Hosp Epidemiol 2004;25:860867.
23.Paramythiotou, E, Lucet, J, Timsit, J, et al. Acquisition of multidrug-resistant Pseudomonas aeruginosa in patients in intensive care units: role of antibiotics with antipseudomonal activity. Clin Infect Dis 2004;38:670677.
24.Schwaber, M, Cosgrove, S, Gold, H, Kaye, K, Carmeli, Y. Fluoroquinolones protective against cephalosporin resistance in gram-negative nosocomial pathogens. Emerg Infect Dis 2004;10:9499.
25.Young, LS, Perdreau-Remington, F, Winston, LG. Clinical, epidemiologic, and molecular evaluation of a clonal outbreak of methicillin-resistant Staphylococcus aureus infection. Clin Infect Dis 2004;38:10751083.
26.Abbo, A, Navon-Venezia, S, Hammer-Muntz, O, Krichali, T, Siegman-Igra, Y, Carmeli, Y. Multidrug-resistant Acinetobacter baumannii. Emerg Infect Dis 2005;11:2229.
27.Ernst, EJ, Raley, G, Herwaldt, LA, Diekema, DJ. Importance of control group selection for evaluating antimicrobial use as a risk factor for methicillin-resistant Staphylococcus aureus bacteremia. Infect Control Hosp Epidemiol 2005;26:634637.
28.Qavi, A, Segal-Maurer, S, Mariano, N, et al. Increased mortality associated with a clonal outbreak of ceftazidime-resistant Klebsiella pneumoniae: a case-control study. Infect Control Hosp Epidemiol 2005;26:6368.


Full text views

Total number of HTML views: 0
Total number of PDF views: 0 *
Loading metrics...

Abstract views

Total abstract views: 0 *
Loading metrics...

* Views captured on Cambridge Core between <date>. This data will be updated every 24 hours.

Usage data cannot currently be displayed